Pharmacopeia Inc., of Princeton, N.J., promoted Michael Stapleton to the newly created position of executive vice president, software operations.
ProQuest Investments L.P., of Princeton, N.J., said Alain Schreiber joined ProQuest as a partner.
Rigel Pharmaceuticals Inc., of South San Francisco, appointed Thomas Volpe to its board of directors.
Schroder Ventures Life Sciences, of Boston, announced several changes in its company. Kevin Street joined Schroder Venture's European team as investment manager, Sarah Young is now an associate of the Life Science team and Tom Daniel was promoted to partner.
SciClone Pharmaceuticals Inc., of San Mateo, Calif., named Jon Saxe and Dean Woodman to its board of directors.
Scios Inc., of Sunnyvale, Calif., promoted George Schreiner to chief scientific officer.